Targeting HIV-1 Envelope on Infected Cell Surfaces to Enable Immune Elimination (R01, No Clinical Trial)
This R01 NOFO seeks basic and translational research to understand how HIV-1 envelope (Env) is regulated on the surface of infected cells and to develop or optimize Env-targeting biologics (engineered antibodies, T/NK cell engagers, CAR T/NK cells) that enhance immune recognition and killing. Projects may use advanced imaging and in situ structural methods to define Env surface dynamics, the s…
HIV-1 infected cells are not efficiently eliminated by host immune responses despite antiviral treatment that suppresses viral replication and spread. The HIV-1 envelope glycoprotein (Env) is the only viral protein expressed on the cell surface. HIV-1 has evolved ways to prevent Env-expressing c…
Funding Source
Eligibility
- Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are also eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Required registrations (must be comp…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers